Head of German medicines body likens HRT to thalidomide.
作者信息
Burgermeister Jane
出版信息
BMJ. 2003 Oct 4;327(7418):767. doi: 10.1136/bmj.327.7418.767.
Abstract
摘要
相似文献
1
Head of German medicines body likens HRT to thalidomide.德国药品监管机构负责人将激素替代疗法比作沙利度胺。
BMJ. 2003 Oct 4;327(7418):767. doi: 10.1136/bmj.327.7418.767.
2
Hormone replacement therapy (HRT), breast cancer and tumor pathology.激素替代疗法（HRT）、乳腺癌和肿瘤病理学。
Maturitas. 2010 Mar;65(3):183-9. doi: 10.1016/j.maturitas.2009.11.005. Epub 2009 Dec 14.
3
Hormone replacement therapy and the risk of breast cancer.激素替代疗法与乳腺癌风险
Eur J Cancer. 2008 Nov;44(16):2344-9. doi: 10.1016/j.ejca.2008.07.041. Epub 2008 Sep 8.
4
HRT and breast cancer.激素替代疗法与乳腺癌
Health News. 2000 Mar;6(3):5.
5
Commentary on 'Hormone replacement therapy use and variations in the risk of breast cancer'.关于“激素替代疗法的使用与乳腺癌风险的差异”的评论
BJOG. 2008 Jun;115(7):918. doi: 10.1111/j.1471-0528.2008.01733.x.
6
Latest on HRT & breast cancer risk.激素替代疗法与乳腺癌风险的最新情况。
Johns Hopkins Med Lett Health After 50. 2000 May;12(3):1-2.
7
20. Oral contraceptives, hormone replacement therapy and breast cancer.
Int J Clin Pract. 2002 Dec;56(10):755-9.
8
[Hormone therapy and breast cancer].[激素疗法与乳腺癌]
Ugeskr Laeger. 2003 Sep 15;165(38):3631-2.
9
Hormone replacement therapy and breast cancer: estimate of risk.激素替代疗法与乳腺癌：风险评估
BMJ. 2005 Aug 6;331(7512):347-9. doi: 10.1136/bmj.331.7512.347.
10
Hormone replacement therapy and mammographic screening.激素替代疗法与乳房X光筛查。
J Br Menopause Soc. 2004 Jun;10(2):75, 80. doi: 10.1258/136218004774202391.
引用本文的文献
1
Analysis of consumer information brochures on osteoporosis prevention and treatment.骨质疏松症预防与治疗的消费者信息手册分析
Ger Med Sci. 2007 Jan 11;5:Doc01.
本文引用的文献
1
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.雌激素加孕激素对健康绝经后妇女乳腺癌及乳腺钼靶检查的影响：妇女健康倡议随机试验
JAMA. 2003 Jun 25;289(24):3243-53. doi: 10.1001/jama.289.24.3243.
Zotero 插件